1AJW image
Deposition Date 1997-05-11
Release Date 1997-11-19
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1AJW
Title:
STRUCTURE OF RHOGDI: A C-TERMINAL BINDING DOMAIN TARGETS AN N-TERMINAL INHIBITORY PEPTIDE TO GTPASES, NMR, 20 STRUCTURES
Biological Source:
Source Organism:
Bos taurus (Taxon ID: 9913)
Method Details:
Experimental Method:
Conformers Calculated:
40
Conformers Submitted:
20
Selection Criteria:
NO DISTANCE VIOLATIONS
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RHOGDI
Gene (Uniprot):ARHGDIA
Chain IDs:A
Chain Length:145
Number of Molecules:1
Biological Source:Bos taurus
Ligand Molecules
Primary Citation
C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases.
Nature 387 814 819 (1997)
PMID: 9194563 DOI: 10.1038/42961

Abstact

The Rho GDP-dissociation inhibitors (GDIs) negatively regulate Rho-family GTPases. The inhibitory activity of GDI derives both from an ability to bind the carboxy-terminal isoprene of Rho family members and extract them from membranes, and from inhibition of GTPase cycling between the GTP- and GDP-bound states. Here we demonstrate that these binding and inhibitory functions of rhoGDI can be attributed to two structurally distinct regions of the protein. A carboxy-terminal folded domain of relative molecular mass 16,000 (M[r] 16K) binds strongly to the Rho-family member Cdc42, yet has little effect on the rate of nucleotide dissociation from the GTPase. The solution structure of this domain shows a beta-sandwich motif with a narrow hydrophobic cleft that binds isoprenes, and an exposed surface that interacts with the protein portion of Cdc42. The amino-terminal region of rhoGDI is unstructured in the absence of target and contributes little to binding, but is necessary to inhibit nucleotide dissociation from Cdc42. These results lead to a model of rhoGDI function in which the carboxy-terminal binding domain targets the amino-terminal inhibitory region to GTPases, resulting in membrane extraction and inhibition of nucleotide cycling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures